I believe that the thesis was that health care companies make heavy investments in R&D that are only profitable because of very high prices in the US, and that these innovations probably wouldn't be available at the lower cost in other other countries without this profit center.
That's just a thesis. It's an interesting one, I'd be interested in reading some discussion of it, especially insightful comments backed with data.